This technology is a targeted therapeutic approach utilizing FLT1/VEGFR1 antagonists to treat poly-ADP ribose polymerase inhibitor (PARPi) resistant tumors.
This technology is a pharmacological intervention targeting localized inflammatory responses in trauma and hemorrhagic shock to prevent multiple organ failure.
This technology is patient-specific engineered model of bone marrow for diagnostics and research of cancer progression using a sample of patient’s serum.
This technology is a bioengineered bone marrow system that can be applied to study various human diseases, toxicity responses, and immune functions in vitro.
This technology is a monoclonal antibody which binds annexin for the inhibition of Funsobacterium nucleatum (Fn) invasion and proliferation to treat and prevent Fn related diseases including ...
This technology is a method to generate squamous epithelial 3D organoids that can mimic the natural physiology of tissues and be used as a personalized pathology model.
This technology is a nucleic acid-based polymer system that can be engineered to target the expression of specific cancer-associated genes for therapeutic benefit.
This technology is a modular platform with engineered tissues linked by vascular perfusion that can be used to study tumor progression and systemic disease in a clinically relevant setting.
